A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy and safety of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study

被引：0

作者：

Ouh, Yung-Taek ^{[1
]}

Song, Seung Hun ^{[2
]}

Kim, Young Tae ^{[3
]}

Cho, Chi-Heum ^{[4
]}

Kim, Tae Jin ^{[5
]}

Min, Seong Su ^{[6
]}

Lee, Do Young ^{[6
]}

Park, Young-Chul ^{[6
]}

Lee, Jae Kwan ^{[7
]}

机构：

[1] Kangwon Natl Univ Hosp, Chuncheon Si, South Korea

[2] Cha Univ, CHA Bundang Med Ctr, Bundang Med Ctr, Seongnam Si, Gyeonggi Do, South Korea

[3] Yonsei Univ, Inst Womens Med Life Sci, Coll Med, Seoul, South Korea

[4] Keimyung Univ, Sch Med, Daegu, South Korea

[5] Konkuk Univ, Sch Med, Seoul, South Korea

[6] BL Corp, Yongin, South Korea

[7] Korea Univ, Guro Hosp, Coll Med, Seoul, South Korea

来源：

GYNECOLOGIC ONCOLOGY | 2023年 / 176卷

关键词：

D O I：

10.1016/j.ygyno.2023.06.208

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1304

引用

页码：S187 / S188

页数：2

共 50 条

[21] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
Croop, R.
Lipton, R. B.
Kudrow, D.
Stock, D. A.
Kamen, L.
Conway, C. M.
Stock, E. G.
Coric, V.
Goadsby, P. J.
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 19 - 19
[22] Efficacy and safety of fasudil in patients with stable angina - A double-blind, placebo-controlled, phase 2 trial
Vicari, RM
Chaitman, B
Keefe, D
Smith, WB
Chrysant, SG
Tonkon, MJ
Bittar, N
Weiss, RJ
Morales-Ballejo, H
Thadani, U
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) : 1803 - 1811
[23] Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trial
Gao, Leili
Bian, Fang
Pan, Tianrong
Jiang, Hongwei
Feng, Bo
Jiang, Chengxia
Sun, Jia
Xiao, Jianzhong
Yan, Pangke
Ji, Linong
DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 280 - 290
[24] Safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial
Correll, Christoph U.
Miller, Andrew C.
Sawchak, Sharon
Kaul, Inder
Paul, Steven M.
Brannan, Stephen K.
CNS SPECTRUMS, 2023, 28 (02) : 220 - 220
[25] Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial
Lin, Jie
Ji, Yuan
Wang, Gaopin
Ma, Xueping
Yao, Zhuhua
Han, Xuebin
Chen, Jie
Chen, Jiyan
Huang, Wei
Xu, Guangma
Peng, Daoquan
Yan, Peishi
Qiao, Ping
He, Yongming
Tang, Yida
Wang, Minghui
Zhang, Mengqi
Yu, Jianjun
Hao, Yu
Ma, Changsheng
ATHEROSCLEROSIS, 2025, 403
[26] Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients with Active Ankylosing Spondylitis
van der Heijde, Desiree
Song, In-Ho
Pangan, Aileen
Deodhar, Atul
Van den Bosch, Filip
Maksymowych, Walter P.
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Everding, Andrea
Sui, Yunxia
Wang, Xin
Chu, Alvina D.
Sieper, Joachim
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[27] Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study
Seino, Yutaka
Sasaki, Takashi
Fukatsu, Atsushi
Ubukata, Michito
Sakai, Soichi
Samukawa, Yoshishige
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) : 1245 - 1255
[28] EFFICACY AND SAFETY OF TAFOLECIMAB IN CHINESE PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (CREDIT-2): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL
Zhou, Yujie
Chai, Meng
He, Yongming
Zhao, Wang
Han, Xuebin
Zhao, Guoyan
Ma, Xueping
Qiao, Ping
An, Pei
Li, Haoyu
Yan, Shuling
Ma, Qingyang
Deng, Huan
Qian, Lei
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1552 - 1552
[29] Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)
Chai, Meng
He, Yongming
Zhao, Wang
Han, Xuebin
Zhao, Guoyan
Ma, Xueping
Qiao, Ping
Shi, Dongmei
Liu, Yuyang
Han, Wei
An, Pei
Li, Haoyu
Yan, Shuling
Ma, Qingyang
Deng, Huan
Qian, Lei
Zhou, Yujie
BMC MEDICINE, 2023, 21 (01)
[30] Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)
Meng Chai
Yongming He
Wang Zhao
Xuebin Han
Guoyan Zhao
Xueping Ma
Ping Qiao
Dongmei Shi
Yuyang Liu
Wei Han
Pei An
Haoyu Li
Shuling Yan
Qingyang Ma
Huan Deng
Lei Qian
Yujie Zhou
BMC Medicine, 21

← 1 2 3 4 5 →